Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2011.0157


Gastric cancer: Practice, Targeted Advances and novel genomics therapeutic approaches.

Prof. Andreas Sendler, M.D., Ph.D

Affiliation: Direktor der Chirurgischen Universitatsklinik, Marienhospital Herne Klinikum der Ruhr-Universitat Bochum, Holkeskampring 40, 44625, Herne, Germany.

E-mail :

Gastric cancer still remains a major health problem worldwide despite a decrease in incidence in the USA and Northwest Europe . Surgery resulting in a complete (R0) tumor resection with D2 lymphadenectomy, if feasible by tumor stage, is the standard approach. Adjuvant chemotherapy can significantly improve overall survival but there is still controversy on optimal regimen and timing of administration (neoadjuvant, perioperative, postoperative). Adjuvant radiotherapy is standard in the USA but its application is limited in Europe or Asia because of its toxicity. Most recently, trastuzumab for advanced HER2-positive gastric cancer has demonstrated substantial efficacy and tolerable toxicity improving overall survival when it is added to systemic chemotherapy. Despite these advances cure rates in advanced stages II and III remain low. Here it is described the effort to achieve the best possible multimodality treatment in individual patients and the future perspectives based on latest advances in cancer genome sequencing, epigenetics, transcriptome and miRNA research towards development of novel agents and markers.

(Citation: Gastric & Breast Cancer 2011; 10(2): 73-78)

You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €33 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 11 March 2011